Related Experiment Video

Updated: Sep 1, 2025

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.5K

Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient

Abhay Srivastava1, Elika Verma1, Cheryl Rockman-Greenberg2

  • 1Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada.

Stem Cell Research
|August 14, 2022
PubMed

Insights

A novel induced pluripotent stem cell (iPSC) line was created from a patient with childhood Hypophosphatasia (HPP). This cell line will advance understanding of HPP molecular mechanisms and explore new therapeutic strategies.

Area of Science:

  • Stem cell biology
  • Genetics
  • Rare diseases

Background:

  • Hypophosphatasia (HPP) is a rare metabolic bone disease.
  • Childhood-onset HPP presents significant challenges in understanding disease mechanisms.
  • Induced pluripotent stem cells (iPSCs) offer a powerful tool for modeling genetic disorders.

Purpose of the Study:

  • To generate and characterize a new human induced pluripotent stem cell (iPSC) line from a patient with childhood-onset Hypophosphatasia (HPP).
  • To establish a valuable in vitro model for studying the molecular pathogenesis of HPP.
  • To facilitate the discovery of novel therapeutic targets and strategies for HPP.

Main Methods:

  • Generation of iPSCs from patient-derived fibroblasts.
  • Genetic characterization of the iPSC line, confirming compound heterozygous mutations in the ALPL gene (c.571G>A and c.1001G>A).
  • Standard stem cell characterization techniques to confirm pluripotency.

Main Results:

  • Successfully generated and characterized a new iPSC line, designated UOMi008-A.
  • The iPSC line harbors the specific compound heterozygous ALPL mutations associated with HPP in the patient.
  • The established iPSC line is suitable for further in vitro studies.

Conclusions:

  • The UOMi008-A iPSC line provides a unique resource for studying childhood-onset HPP.
  • This model will aid in elucidating the molecular basis of HPP.
  • The iPSC line holds potential for advancing therapeutic development for Hypophosphatasia.

More Related Videos

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.4K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.3K

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K